Glenmede Trust CO Na Eagle Pharmaceuticals, Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$41.72 - $51.34 $10,763 - $13,245	-258 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $6,293 - $8,717	170 Added 193.18%	258 $10,000
Q2 2020 Aug 14, 2020	BUY	$43.24 - $55.02 $518 - $660	12 Added 15.79%	88 $4,000
Q3 2019 Nov 14, 2019	BUY	$53.25 - $59.98 $2,396 - $2,699	45 Added 145.16%	76 $4,000
Q1 2019 May 14, 2019	SELL	$38.66 - $51.82 $966 - $1,295	-25 Reduced 44.64%	31 $1,000
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $2,056 - $3,792	56 New	56 $2,000

8.58M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $8.46M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.